Asset Purchase and Settlement Agreement Sample Contracts

Asset purchase and settlement agreement for complement inhibition technology including Soliris (eculizumab)
Asset Purchase and Settlement Agreement • September 21st, 2021 • Oklahoma

The Oklahoma Medical Research Foundation and Alexion Pharma has agreed to acquire from OMRF all rights to certain patents related to complement-inhibition technology.